These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9627039)

  • 41. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration.
    Fry AC; Singh DK; Chandna SM; Farrington K
    Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta2-microglobulin clearance with super high flux hemodialysis: an ex vivo study.
    Lee WC; Uchino S; Fealy N; Baldwin I; Panagiotopoulos S; Goehl H; Morgera S; Neumayer HH; Bellomo R
    Int J Artif Organs; 2003 Aug; 26(8):723-7. PubMed ID: 14521169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Towards long-term dialysis: a personal view.
    Davison AM
    Artif Organs; 1999 Jan; 23(1):6-9. PubMed ID: 9950172
    [No Abstract]   [Full Text] [Related]  

  • 44. Serum beta 2-microglobulin levels in patients chronically dialyzed with CA-210 versus CT-190 dialysis membranes.
    DeFranco P; Farrell J; Gellens M; Bastani B
    Am J Nephrol; 1998; 18(1):16-20. PubMed ID: 9481434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.
    Ouseph R; Hutchison CA; Ward RA
    Nephrol Dial Transplant; 2008 May; 23(5):1704-12. PubMed ID: 18156455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 47. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
    Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
    Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
    Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
    Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Removal of β2-Microglobulin in Spent Dialysate Cannot Be Monitored by Spectrophotometric Analysis.
    Donadio C; Calia D; Ghimenti S; Onor M; Colombini E; Fuoco R; Di Francesco F
    Blood Purif; 2015; 40(2):109-12. PubMed ID: 26183959
    [No Abstract]   [Full Text] [Related]  

  • 50. Optimal reuse of cuprammonium rayon hollow-fibre dialyzers.
    Chan MK; Lau N
    Int J Artif Organs; 1989 Apr; 12(4):223-8. PubMed ID: 2656538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Hemophan and Cuprophan dialysis on beta-2 microglobulin levels, exercise capacity, and symptoms scores.
    Tomson CV; Woffindin C; Sheldon W; Hoenich NA
    Nephrol Dial Transplant; 1988; 3(3):355-6. PubMed ID: 3140115
    [No Abstract]   [Full Text] [Related]  

  • 52. [Dialysis amyloidosis and beta-2-microglobulin].
    Sulková S; Votruba T
    Cas Lek Cesk; 1989 Jan; 128(3):68-73. PubMed ID: 2655913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Revisiting the role of flux in beta2-microglobulin removal.
    Hoenich NA
    Blood Purif; 2007; 25(5-6):430-1. PubMed ID: 17957096
    [No Abstract]   [Full Text] [Related]  

  • 54. [Alteration of beta2-microglobulin metabolism in terminal chronic renal insufficiency (author's transl)].
    Vincent C; Revillard JP; Traeger J
    Pathol Biol (Paris); 1978 Sep; 26(6):303-6. PubMed ID: 83569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pilot, randomized, double-blind, cross-over study of high cut-off versus high-flux dialysis membranes.
    Lee D; Haase M; Haase-Fielitz A; Paizis K; Goehl H; Bellomo R
    Blood Purif; 2009; 28(4):365-72. PubMed ID: 19729908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carpal tunnel syndrome and plasma beta2-microglobulin concentration in hemodialysis patients.
    Shin J; Nishioka M; Shinko S; Shibuya K; Sugiki M; Kasumoto H; Fudo A; Bito Y; Fujita Y; Komaba K
    Ther Apher Dial; 2008 Feb; 12(1):62-6. PubMed ID: 18257814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of hemodialysis on the concentration of beta 2-microglobulin and acute phase proteins in the serum of patients with chronic renal failure].
    Starzyk J; Bartelik S; Kowalski D
    Wiad Lek; 1990 Feb 1-15; 43(3-4):114-7. PubMed ID: 1695043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term clinical experience with PMMA membrane.
    Aoike I
    Contrib Nephrol; 1999; 125():205-12. PubMed ID: 9895442
    [No Abstract]   [Full Text] [Related]  

  • 59. Behaviour of beta2-microglobulin removal with different dialysis schedules.
    David S; Bottalico D; Tagliavini D; Mandolfo S; Scanziani R; Cambi V
    Nephrol Dial Transplant; 1998; 13 Suppl 6():49-54. PubMed ID: 9719205
    [No Abstract]   [Full Text] [Related]  

  • 60. Testing protein permeability of dialysis membranes using SDS-PAGE.
    Mann H; Melzer H; Al-Bashir A; Xu XQ; Stiller S
    Int J Artif Organs; 2002 May; 25(5):441-6. PubMed ID: 12074343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.